深交所：将百奥赛图-B调入港股通

Core Viewpoint - The Shenzhen Stock Exchange announced the adjustment of the Hong Kong Stock Connect eligible securities list, specifically including Baidu Biotechnology-B (02315) due to its A-share listing meeting the 10 trading days requirement and the end of its price stabilization period in the Hong Kong market, effective from December 24, 2025 [1]. Group 1 - The adjustment involves Baidu Biotechnology-B being included in the Hong Kong Stock Connect [1][3]. - The decision is based on the company's A-share listing having been active for 10 trading days [1]. - The price stabilization period for Baidu Biotechnology-B in the Hong Kong market has concluded [1].